Records containing: HHT

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-10-27
A Phase II/III Randomized, Placebo Controlled, Double Blind Study to Evaluate the Effects of up to 24 Weeks of Low Dose Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia
CLINICAL_TRIALS study record update · 2026-04-22
Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
CLINICAL_TRIALS study record update · 2026-03-19
A Phase II/III Randomized, Placebo Controlled, Double Blind Study to Evaluate the Effects of up to 24 Weeks of Low Dose Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia
CLINICAL_TRIALS study record update · 2026-01-14
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
CLINICAL_TRIALS study record update · 2025-03-17
Genotype-phenotype Association Study of ENG and ACVRL1 Genes in the Inflammatory and Endothelial Response in Hereditary Hemorrhagic Telangiectasia (HHT)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-12-10
Tourniquet-Test in HHT
CLINICAL_TRIALS study record update · 2023-09-15
Subsequent Bevacizumab Treatment in Patients With HHT After the End of BABH Interventional Study. A Descriptive Study.
CLINICAL_TRIALS study record update · 2021-02-15
Intranasal Bevacizumab for HHT-Related Epistaxis
CLINICAL_TRIALS study record update · 2013-08-12
A Randomized Double Blind Placebo Controlled Trial of Intranasal Submucosal Bevacizumab in Hereditary Hemorrhagic Telangiectasia